右美托咪定对肠源性脓毒症大鼠小肠黏膜损伤的改善作用及其机制

doi:10.13481/j.1671-587X.20250401

Abstract

Abstract:

Objective To discuss the protective effect of dexmedetomidine （DEX） on intestinal function in rats with enterogenous sepsis， and to clarify its potential mechanism based on E2F transcription factor 1 （E2F1）/nuclear factor kappa B （NF-κB） signaling pathway. Methods Sixty SD rats were selected， among which 50 rats were used to establish enterogenous sepsis models by cecal ligation and puncture （CLP）， and the remaining 10 rats were used as sham operation group （only cecal separation without ligation or puncture）. The 40 successfully modeled rats were randomly divided into model group， low dose of DEX group， medium， doses of DEX group， and high dose of DEX group， with 10 rats in each group. The rats in low， medium， and high dose of DEX groups were intraperitoneally injected with 20， 40 and 60 μg·kg^-1 DEX immediately after modeling， while the rats in sham operation group and model group were intraperitoneally injected with the same volume of saline. After 24 h of administration， the intestinal myoelectric activities of the rats in various groups were detected； the colony counts of Escherichia coli， Lactobacillus and Bifidobacterium in cecal contents of the rats in various groups were detected； the pathomorphology of small intestinal tissue of the rats was observed by HE staining； the levels of secretory immunoglobulin A （sIgA） in supernatant of small intestinal tissue homogenate and the levels of diamine oxidase （DAO） and D-lactic acid in serum of the rats in various groups were detected by kit； real-time fluorescence quantitative PCR （RT-qPCR） method was used to detect the mRNA expression levels of macrophage polarization markers in small intestinal tissues of the rats in various groups； Western blotting method was used to detect the protein expression levels of macrophage polarization markers， E2F1， phosphorylated NF-κB p65 （p-NF-κB p65）， and NF-κB p65 in small intestinal tissue of the rats in various groups. Results Compared with sham operation group， the slow wave frequency and amplitude of intestinal smooth muscle of the rats in model group were decreased （P<0.05）； compared with model group， the slow wave amplitude of intestinal smooth muscle of the rats in low dose of DEX groups was increased （P<0.05）， the slow wave frequency and amplitude of intestinal smooth muscle of the rats in medium and high doses of DEX groups were increased （P<0.05）； compared with low dose of DEX group， the slow wave frequency and amplitude of the rats in medium and high doses of DEX groups were increased （P<0.05）； compared with medium dose of DEX group， the slow wave frequency and amplitude of intestinal smooth muscle of the rats in high dose of DEX group were increased （P<0.05）. Compared with sham operation group， the colony count of Escherichia coli in intestinal tract of the rats in model group was increased （P<0.05）， while the colony counts of Bifidobacterium and Lactobacillus were decreased （P<0.05）； compared with model group， the colony count of Bifidobacterium in intestinal tract of the rats in low dose of DEX group was decreased （P<0.05）， the colony count of Escherichia coli in intestinal tract of the rats in medium， and high doses of DEX groups was decreased （P<0.05）， while the colony counts of Bifidobacterium and Lactobacillus were increased （P<0.05）； compared with low dose of DEX group， the colony count of Escherichia coli in intestinal tract of the rats in medium and high dose of DEX groups was decreased （P<0.05）， while the colony counts of Bifidobacterium and Lactobacillus were increased （P<0.05）； compared with medium dose of DEX group， the colony count of Escherichia coli in intestinal tract of the rats in high dose of DEX group was decreased （P<0.05）， while the colony counts of Bifidobacterium and Lactobacillus were increased （P<0.05）. The HE staining results showed that the small intestinal mucosal structure in sham operation group was normal and intact； the small intestinal mucosal epithelial cells in model group were necrotic， with damaged， collapsed and disordered villi； Compared with model groups， the pathological changes of small intestinal tissues in low， medium， and high doses of DEX groups were improved. Compared with sham operation group， the level of sIgA in supernatant of small intestinal tissue homogenate of the rats in model group was decreased （P<0.05）， while the protein expression levels of DAO and D-lactic acid in serum were increased （P<0.05）； compared with model group， the level of DAO in serum of the rats in low dose of DEX groups was decreased （P<0.05）， the level of sIgA in supernatant of small intestinal tissue homogenate of the rats in medium and high doses of DEX groups was increased （P<0.05）， while the protein expression levels of DAO and D-lactic acid in serum were decreased （P<0.05）； compared with low dose of DEX group， the level of sIgA in supernatant of small intestinal tissue homogenate of the rats in medium and high doses of DEX groups was increased （P<0.05）， while the protein expression levels of DAO and D-lactic acid in serum were decreased （P<0.05）； compared with medium dose of DEX group， the level of sIgA in supernatant of small intestinal tissue homogenate of the rats in high dose of DEX group was significantly increased （P<0.05）， while the protein expression levels of DAO and D-lactic acid in serum were decreased （P<0.05）. The RT-qPCR results and Western blotting results showed that compared with sham operation group， the mRNA and protein expression levels of CD86， monocyte chemoattractant protein-1 （MCP-1）， and CD80 in small intestinal tissue of the rats in model group were increased （P<0.05）， while the mRNA and protein expression levels of CD206， interleukin-4 （IL-4） and， CD163 were decreased （P<0.05）； compared with model group， the expression levels of CD80 mRNA， CD86 protein and MCP-1 protein in small intestinal tissue of the rats in low dose of DEX group were decreased （P<0.05）， and the expression levels of IL-4 mRNA， CD163 mRNA， CD206 protein， and CD163 protein were decreased （P<0.05）， the mRNA and protein expression levels of CD86， MCP-1， and CD80 in small intestinal tissue of the rats in medium and high doses of DEX groups were decreased （P<0.05）， while the mRNA and protein expression levels of CD206， IL-4 and CD163 were increased （P<0.05）； compared with low dose of DEX group， the mRNA and protein expression levels of CD86， MCP-1， and CD80 in small intestinal tissue of the rats in medium and high doses of DEX groups were decreased （P<0.05）， while the mRNA and protein expression levels of CD206， IL-4， and CD163 were increased （P<0.05）； compared with medium dose of DEX group， the mRNA and protein expression levels of CD86， MCP-1， and CD80 in small intestinal tissue of the rats in high dose of DEX group were decreased （P<0.05）， while the mRNA and protein expression levels of CD206， IL-4， and CD163 were increased （P<0.05）. The Western blotting results showed that compared with sham operation group， the protein expression level of E2F1 in small intestinal tissue of the rats in model group was decreased （P<0.05）， while the ratio of p-NF-κB p65/NF-κB p65 was increased （P<0.05）； compared with model group， the protein expression levels of E2F1 and ratio of p-NF-κB p65/NF-κB p65 in small intestinal tissue of the rats in low， medium and high doses of DEX groups were decreased （P<0.05）； compared with low dose of DEX group， the protein expression level of E2F1 in small intestinal tissue of the rats in medium and high doses of DEX groups was increased （P<0.05）， while the ratio of p-NF-κB p65/NF-κB p65 was decreased （P<0.05）； compared with medium dose of DEX group， the protein expression level of E2F1 in small intestinal tissue of the rats in high dose of DEX group was increased （P<0.05）， while the ratio of p-NF-κB p65/NF-κB p65 was decreased （P<0.05）. Conclusion DEX can improve the small intestinal mucosal injury in the rats with enterogenous sepsis and promote the polarization of macrophages to M2 type in small intestinal tissues， and its mechanism may be related to the regulation of E2F1/NF-κB signaling pathway by DEX.

Key words: Dexmedetomidine, E2F transcription factor 1, Nuclear factor kappa B, Macrophage polarization, Enterogenous sepsis

CLC Number:

R614

Kun YANG,Qianyao FU,Yongqiang SUN,Kun YANG,Jun MENG. Protective effect of dexmedetomidine on intestinal mucosal injury in rats with enterogenous sepsis and its mechanism[J].Journal of Jilin University(Medicine Edition), 2025, 51(4): 855-865.

Figures/Tables 9

Tab. 1

Tab. 2

Fig. 1

Tab.3

Fig. 2

Tab.4

Tab.5

Fig. 3

Tab.6

References 28

[1]	YE G J， YE L Q， ZHOU J Q， et al. Challenges in diagnosing community-acquired carbapenem-susceptible Acinetobacter baumannii enterogenic sepsis： a case report［J］. Medicine （Baltimore）， 2019， 98（26）： e16248.
[2]	房槟，曹晓瑞，闫昭，等. MOTS-c通过TLR4对肠源性脓毒症的作用及其机制［J］. 现代生物医学进展， 2020， 20（5）： 843-847， 905.
[3]	林耀国，刘卫明，魏志亮. 垂体后叶素联合去甲肾上腺素治疗肠源性脓毒性休克患者的效果分析［J］. 医学理论与实践， 2021， 34（2）： 240-242.
[4]	刘梦菲，何龙，田丹丹，等. 艾司氯胺酮复合右美托咪定行无阿片麻醉对乳腺癌改良根治术患者术后恢复质量的影响［J］. 郑州大学学报（医学版）， 2023， 58（3）：363-366.
[5]	徐颖，马四清. 右美托咪定对肠源性脓毒症大鼠肠屏障功能保护及抗凋亡作用的机制研究［J］. 广西医科大学学报， 2021， 38（7）： 1313-1318.
[6]	奚高原，丁成智，孟睿，等. 右美托咪定对食管癌Eca-109细胞LINC00982表达及生物学行为的影响［J］. 郑州大学学报（医学版）， 2023， 58（1）： 13-18.
[7]	董岩，贾依娜尔，吐尔逊古丽·麦麦提，等. 抑制AKR1B1表达通过调控巨噬细胞极化改善大鼠脓毒症所致急性肺损伤［J］. 河北医药， 2024， 46（15）： 2245-2250.
[8]	FOUAD S， HAUTON D， D’ANGIOLELLA V. E2F1： cause and consequence of DNA replication stress［J］. Front Mol Biosci， 2021， 7： 599332.
[9]	ZHU L， DOU Z M， WU W， et al. Ghrelin/GHSR axis induced M2 macrophage and alleviated intestinal barrier dysfunction in a sepsis rat model by inactivating E2F1/NF-κB signaling［J］. Can J Gastroenterol Hepatol， 2023， 2023： 1629777.
[10]	李锦灵，黄树武，李舸，等. 大鼠脓毒症模型的凝血功能研究［J］. 中国实验动物学报， 2018， 26（2）： 224-229.
[11]	郑文贺，闫超. 地锦草总黄酮对肠源性脓毒症大鼠的肠道保护作用［J］. 福建中医药， 2022， 53（1）： 35-39.
[12]	谭莉，陈建丽，倪佳. 儿童肠源性感染诱发脓毒症及多器官功能障碍临床分析［J］. 贵州医药， 2015， 39（3）： 227-228.
[13]	叶森青，苏懿，张云海，等. 脓毒症中医证型分布、死亡因素分析及AT-Ⅲ联合NT-proBNP、SOFA评分对预后的评估价值［J］. 新中医， 2024， 56（7）： 86-91.
[14]	宋林，邹惠，曾玲，等. 脓毒症患儿预后的影响因素分析及pSOFA评分、PCIS评分及早期血乳酸测定的预测价值探讨［J］. 现代生物医学进展， 2023， 23（3）： 494-499.
[15]	梁群，张烁. 中医药治疗脓毒症肠屏障损伤的研究进展［J］. 辽宁中医杂志， 2021， 48（3）： 203-206.
[16]	孙一凡，戴林峰，袁思成，等. 针刺治疗脓毒症胃肠功能障碍临床研究进展［J］. 中国中医药图书情报杂志， 2020， 44（6）： 68-70.
[17]	刘杰，费蕾，柳梅. 糖皮质激素对脓毒症休克大鼠肠道功能的保护作用［J］. 内科急危重症杂志， 2016， 22（1）： 72-73， 78.
[18]	陈朴，赵静，吴琼，等. 不同营养支持方式对脓毒症患儿肠道屏障功能及肠源性感染指标的影响［J］. 中华医院感染学杂志， 2023， 33（1）： 142-146.
[19]	ZHANG H L， LU Y， ZHANG Y L， et al. DHA-enriched phosphatidylserine ameliorates cyclophosphamide-induced liver injury via regulating the gut-liver axis［J］. Int Immunopharmacol， 2024， 140： 112895.
[20]	WANG C Y， LIU Y X， HE Y Y， et al. Combined effects of TiO₂ nanoparticle and fipronil co-exposure on microbiota in mouse intestine［J］. Food Chem Toxicol， 2024， 192： 114931.
[21]	LIU Y M， JU M J， PAN S M， et al. Relationship between blood lactate level and the prognosis of patients with diabetic sepsis［J］. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue， 2017， 29（8）： 689-693.
[22]	GE Z L， CHEN Y， MA L K， et al. Macrophage polarization and its impact on idiopathic pulmonary fibrosis［J］. Front Immunol， 2024， 15： 1444964.
[23]	TAO X Y， WANG J L， LIU B， et al. Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis［J］. Front Immunol， 2024， 15： 1338744.
[24]	YANG Z B， XIA H， LAI J W， et al. Artesunate alleviates sepsis-induced liver injury by regulating macrophage polarization via the lncRNA MALAT1/PTBP1/IFIH1 axis［J］. Diagn Microbiol Infect Dis， 2024， 110（1）： 116383.
[25]	SHIMIZU J， MURAO A， LEE Y C， et al. Extracellular CIRP promotes Kupffer cell inflammatory polarization in sepsis［J］. Front Immunol， 2024， 15： 1411930.
[26]	ZHANG Q N， DAI J T， LIN Y Z， et al. Isobavachalcone alleviates ischemic stroke by suppressing HDAC1 expression and improving M2 polarization［J］. Brain Res Bull， 2024， 211： 110944.
[27]	YI J Z， LI B B， YIN X M， et al. CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression［J］. Oncol Res， 2024， 32（6）： 1129-1139.
[28]	HUANG Y L， CHEN R， ZHOU J W. E2F1 and NF-κB： key mediators of inflammation-associated cancers and potential therapeutic targets［J］. Curr Cancer Drug Targets， 2016， 16（9）： 765-772.

Group	Slow wave frequency（f/Hz）	Slow wave amplitude（mV）
Sham operation	17.75±1.35	0.41±0.03
Model	9.47±1.05^*	0.14±0.02^*
DEX Low dose	10.38±0.92	0.19±0.01^△
Medium dose	13.29±1.15^△#	0.25±0.03^△#
High dose	15.14±1.23^△#○	0.32±0.02^△#○
F	87.674	210.556
P	<0.001	<0.001

Group	Colony count of Escherichia coli	Colony count of Bifidobacteria	Colony count of Lactobacillus
Sham operation	5.24±0.25	12.35±1.05	9.30±0.83
Model	14.82±0.84^*	5.52±0.34^*	3.75±0.24^*
DEX Low dose	13.97±0.97	6.17±0.53^△	3.51±0.54
Medium dose	10.53±0.37^△#	8.37±0.48^△#	5.10±0.38^△#
High dose	7.95±0.61^△#○	9.35±0.76^△#○	6.32±0.40^△#○
F	365.612	161.257	207.159
P	<0.001	<0.001	<0.001

Group	sIgA [ρ_B/(mg·L^-1)]	DAO [ρ_B/(mg·L^-1)]	D-lactic acid [λ_B/(U·L^-1)]
Sham operation	29.75±3.51	8.18±0.68	21.28±2.28
Model	13.84±1.08^*	14.32±1.27^*	47.36±3.62^*
DEX Low dose	15.24±1.93	13.15±1.10^△	44.18±4.25
Medium dose	19.37±2.21^△#	11.29±0.96^△#	36.47±2.98^△#
High dose	24.34±1.67^△#○	9.65±0.81^△#○	31.23±1.30^△#○
F	87.207	64.256	115.999
P	<0.001	<0.001	<0.001

Group	CD86 mRNA	MCP-1 mRNA	CD80 mRNA	CD206 mRNA	IL-4 mRNA	CD163 mRNA
Sham operation	1.02±0.09	1.03±0.10	1.04±0.17	1.01±0.11	1.03±0.07	1.05±0.09
Model	3.28±0.28^*	4.04±0.32^*	5.94±0.41^*	0.38±0.03^*	0.27±0.02^*	0.51±0.04^*
DEX Low dose	3.12±0.24	3.82±0.35	5.41±0.48^△	0.42±0.07	0.33±0.03^△	0.56±0.05^△
Medium dose	2.68±0.23^△#	3.25±0.30^△#	4.52±0.41^△#	0.58±0.03^△#	0.52±0.04^△#	0.64±0.04^△#
High dose	2.24±0.21^△#○	2.51±0.24^△#○	3.42±0.32^△#○	0.76±0.04^△#○	0.67±0.05^△#○	0.82±0.07^△#○
F	169.954	193.235	270.424	165.686	450.874	130.294
P	<0.001	<0.001	<0.001	<0.001	<0.001	<0.001

Group	CD86 protein	MCP-1 protein	CD80 protein	CD206 protein	IL-4 protein	CD163 protein
Sham operation	0.18±0.02	0.16±0.01	0.17±0.02	0.92±0.08	0.95±0.08	0.93±0.08
Model	0.91±0.08^*	0.87±0.07^*	0.89±0.07^*	0.12±0.01^*	0.15±0.01^*	0.13±0.01^*
DEX Low dose	0.82±0.06^△	0.76±0.08^△	0.84±0.09	0.18±0.01^△	0.17±0.01	0.19±0.02^△
Medium dose	0.65±0.05^△#	0.68±0.06^△#	0.73±0.06^△#	0.35±0.04^△#	0.37±0.03^△#	0.34±0.03^△#
High dose	0.26±0.02^△#○	0.34±0.03^△#○	0.28±0.02^△#○	0.68±0.05^△#○	0.72±0.06^△#○	0.75±0.08^△#○
F	406.504	282.138	319.167	543.925	557.748	440.915
P	<0.001	<0.001	<0.001	<0.001	<0.001	<0.001

Protective effect of dexmedetomidine on intestinal mucosal injury in rats with enterogenous sepsis and its mechanism

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References 28

Related Articles 15

Metrics

Comments

Recommended 0

Group	E2F1 protein	Ratio of p-NF-κB p65/NF-κB p65
Sham operation	0.91±0.05	0.14±0.01
Model	0.12±0.02^*	0.73±0.04^*
DEX Low dose	0.34±0.02^△	0.65±0.05^△
Medium dose	0.58±0.04^△#	0.33±0.02^△#
High dose	0.75±0.05^△#○	0.28±0.02^△#○
F	673.986	637.300
P	<0.001	<0.001

[1]	Hongjie LI,Maozhuo LAN,Xiao WANG,Ranran FENG,Yanyan TAO,Jiaqing LIU,Haibai SUN. Effect of BTK inhibitor BGB-3111 combined with bortezomib on apoptosis of human multiple myeloma cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 599-609.
[2]	Xiaoxia HU,Yalong LI,Dongliang YANG,Bazeren LA,Xinyue LIU. Effect of high glucose on polarization of Raw264.7 macrophages in vitro [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 403-411.
[3]	Tan CHEN,Yan CHEN. Research progress in mechanism of fibrosis regulated by macrophage polarization [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1465-1473.
[4]	Shilei GAO,Jiaqiang WANG,Weitao YAO,Zhichao TIAN,Chao LI,Xiaoxiao LIANG,Xin WANG. Effect of miR-761 on epithelial-mesenchymal transition in osteosarcoma MG63 cells by regulating tumor-associated macrophage polarization [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 978-988.
[5]	Yiyan YU,Zhimin ZHANG,Jiawen CHEN,Xin LIU,Yan LI,Hongyan ZHAO. Research progress in relationship between macrophage polarization and oral diseases [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 864-871.
[6]	Haitao LI, Qin LI, Fei CAI, Guofu HU, Yunfei TENG. Effect of apigenin on polarization and inflammation of mouse RAW264.7 macrophages and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 549-556.
[7]	Jing ZHANG,Shaoheng WANG,Pengfei LIU,Lei. GUAN. Effects of continuous infusion of dexmedetomidine on lactate metabolism and postoperative recovery in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1305-1313.
[8]	Qi LIU,Xin XU,Zhenggen WANG. Effect of calycosin on intestinal mucosal barrier function in cirrhosis rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 391-398.
[9]	Hexin MAO,Linyuan WANG,Ning GUAN,Xiuqiu GAO. Effect of gallic acid on polarization of M1 macrophages [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1139-1145.
[10]	YANG Wenqiang, HE Xin, BAI Xue, YU Lu, LI Zongze, ZHANG Jiayue, YANG Jing. Effects of carnosine on oxidative stress and NF-κB signaling pathway in rats with vascular cognitive impairment [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 329-334.
[11]	HOU Hailong, TANG Ying, QU Xinglong, HUA Shucheng. Clinical effect of dexmedetomidine combined with non-invasive positive pressure ventilation in treatment of patients with AECOPD complicated with pulmonary encephalopathy and evaluation on its safety [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1014-1019.
[12]	WANG Haibin, DONG Zhijun, GUO Litao, SHI Jing, DONG Weili. Protective effect of Purendan Superfine Powder on retinopathy of rats with diabetes mellitus induced by streptozotocin and its influence in NF-κB signaling pathway [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 759-763.
[13]	YANG Wenyan, LIU Qiang, SUN Zhijuan, DU Liqing, XU Chang, WANG Yan, LIU Yang, WANG Qin. Effect of melatonin on radiosensitivity of non-small cell lung cancer H1299 cells [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 532-536.
[14]	CAO Xuefeng, ZHAO Liang, LIU Xudong, LI Yan, ZHEN Ruixin, DUAN Fengmei, LIU Yuling. Sedative effect of non-intravenous administration dexmedetomidine in pediatric patients underwent lower abdomen and limb surgery [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 388-393.
[15]	WANG Bo, SHEN Qianqian, ZHANG Hua, FENG Zhiying. Evaluation on postoperative analgesia efficacy of oxycodone combined with dexmedetomidine in patients underwent laparoscopic radical surgery of colon cancer [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1231-1236.